Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Operating Margin 2010-2025 | HYPMY

Current and historical operating margin for Hypermarcas (HYPMY) over the last 10 years. The current operating profit margin for Hypermarcas as of March 31, 2025 is 11.34%.
  
Hypermarcas Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $1.20B $0.18B 15.23%
2024-12-31 $1.38B $0.34B 24.51%
2024-09-30 $1.50B $0.44B 29.27%
2024-06-30 $1.60B $0.50B 31.45%
2024-03-31 $1.63B $0.52B 31.82%
2023-12-31 $1.59B $0.50B 31.78%
2023-09-30 $1.62B $0.53B 32.88%
2023-06-30 $1.57B $0.51B 32.65%
2023-03-31 $1.50B $0.50B 32.96%
2022-12-31 $1.46B $0.48B 32.99%
2022-09-30 $1.35B $0.45B 33.09%
2022-06-30 $1.27B $0.42B 33.02%
2022-03-31 $1.17B $0.40B 33.70%
2021-12-31 $1.10B $0.37B 33.27%
2021-09-30 $1.02B $0.33B 32.58%
2021-06-30 $0.91B $0.30B 32.42%
2021-03-31 $0.82B $0.27B 32.52%
2020-12-31 $0.79B $0.26B 32.24%
2020-09-30 $0.81B $0.24B 29.40%
2020-06-30 $0.87B $0.24B 27.63%
2020-03-31 $0.92B $0.23B 24.54%
2019-12-31 $0.84B $0.28B 32.93%
2019-09-30 $0.84B $0.31B 36.39%
2019-06-30 $0.83B $0.31B 36.88%
2019-03-31 $0.84B $0.33B 39.40%
2018-12-31 $1.02B $0.34B 32.97%
2018-09-30 $1.06B $0.34B 31.89%
2018-06-30 $1.12B $0.36B 31.94%
2018-03-31 $1.13B $0.36B 32.18%
2017-12-31 $1.14B $0.36B 31.93%
2017-09-30 $1.11B $0.36B 32.43%
2017-06-30 $1.06B $0.35B 32.80%
2017-03-31 $1.03B $0.34B 32.88%
2016-12-31 $0.94B $0.31B 32.56%
2016-09-30 $0.39B $0.28B 71.50%
2016-06-30 $0.52B $0.27B 52.60%
2016-03-31 $0.70B $0.24B 34.24%
2015-12-31 $0.90B $0.27B 29.90%
2015-09-30 $1.72B $0.29B 17.08%
2015-06-30 $1.82B $0.29B 15.81%
2015-03-31 $1.92B $0.35B 18.17%
2014-12-31 $1.97B $0.36B 18.30%
2014-09-30 $1.96B $0.41B 20.78%
2014-06-30 $1.99B $0.46B 23.24%
2014-03-31 $1.95B $0.41B 21.01%
2013-12-31 $1.95B $0.39B 19.73%
2013-09-30 $1.98B $0.41B 20.53%
2013-06-30 $1.97B $0.39B 19.92%
2013-03-31 $1.98B $0.42B 21.27%
2012-12-31 $1.96B $0.36B 18.51%
2012-09-30 $1.78B $0.29B 16.23%
2012-06-30 $1.84B $0.22B 11.88%
2012-03-31 $1.96B $0.21B 10.48%
2011-12-31 $2.00B $0.25B 12.66%
2011-09-30 $2.21B $0.29B 13.16%
2011-06-30 $2.12B $0.35B 16.29%
2011-03-31 $1.96B $0.33B 16.74%
2010-12-31 $1.81B $0.32B 17.49%
2010-09-30 $1.65B $0.26B 15.62%
2010-06-30 $1.44B $0.24B 16.53%
2010-03-31 $1.22B $0.24B 19.22%
2009-12-31 $1.03B $0.20B 19.24%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.676B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.033B 26.94
Zoetis (ZTS) United States $68.299B 24.78
Takeda Pharmaceutical (TAK) Japan $47.729B 9.74
Daiichi Sankyo, - (DSNKY) Japan $47.567B 24.38
BeOne Medicines - (ONC) Switzerland $35.221B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.101B 0.00
Summit Therapeutics (SMMT) United States $19.827B 0.00
Merck (MKKGY) Germany $17.079B 11.11
Shionogi (SGIOY) Japan $15.193B 15.22
United Therapeutics (UTHR) United States $14.124B 12.22
Neurocrine Biosciences (NBIX) United States $13.181B 39.32
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.601B 0.00
Madrigal Pharmaceuticals (MDGL) United States $8.212B 0.00
Corcept Therapeutics (CORT) United States $7.560B 63.49
Grifols, S.A (GRFS) Spain $7.371B 0.00
Ionis Pharmaceuticals (IONS) United States $6.978B 0.00
Stevanato Group S.p.A (STVN) Italy $6.850B 40.39
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $3.807B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.968B 14.10
Crinetics Pharmaceuticals (CRNX) United States $2.893B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.815B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.476B 8.29
Centessa Pharmaceuticals (CNTA) United Kingdom $2.420B 0.00
Ocular Therapeutix (OCUL) United States $2.196B 0.00
Dyne Therapeutics (DYN) United States $1.761B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.757B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.615B 24.06
Guardian Pharmacy Services (GRDN) United States $1.495B 0.00
Ardelyx (ARDX) United States $1.439B 0.00
Harrow (HROW) United States $1.436B 0.00
ARS Pharmaceuticals (SPRY) United States $1.436B 0.00
Evotec AG (EVO) Germany $1.335B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.329B 0.00
Xeris Biopharma Holdings (XERS) United States $1.240B 0.00
Enliven Therapeutics (ELVN) United States $1.198B 0.00
Collegium Pharmaceutical (COLL) United States $1.189B 6.50
Cronos Group (CRON) Canada $0.908B 0.00
Akebia Therapeutics (AKBA) United States $0.862B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.713B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.709B 7.30
ProKidney (PROK) United States $0.691B 0.00
Theravance Biopharma (TBPH) United States $0.662B 54.79
KalVista Pharmaceuticals (KALV) United States $0.643B 0.00
Relay Therapeutics (RLAY) United States $0.610B 0.00
Bioventus (BVS) United States $0.609B 14.74
Siga Technologies (SIGA) United States $0.609B 7.52
Organogenesis (ORGO) United States $0.600B 0.00
Elite Pharmaceuticals (ELTP) United States $0.581B 0.00
Tourmaline Bio (TRML) United States $0.580B 0.00
Oruka Therapeutics (ORKA) United States $0.576B 0.00
USANA Health Sciences (USNA) United States $0.555B 11.39
Xencor (XNCR) United States $0.548B 0.00
Zevra Therapeutics (ZVRA) United States $0.529B 0.00
Savara (SVRA) United States $0.525B 0.00
Nektar Therapeutics (NKTR) United States $0.518B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.450B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Aquestive Therapeutics (AQST) United States $0.410B 0.00
Nanobiotix S.A (NBTX) France $0.379B 0.00
4D Molecular Therapeutics (FDMT) United States $0.339B 0.00
Larimar Therapeutics (LRMR) United States $0.332B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Altimmune (ALT) United States $0.320B 0.00
AleAnna (ANNA) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 19.01
OmniAb (OABI) United States $0.245B 0.00
Galectin Therapeutics (GALT) United States $0.226B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Lyell Immunopharma (LYEL) United States $0.203B 0.00
Aclaris Therapeutics (ACRS) United States $0.203B 0.00
MediWound (MDWD) Israel $0.196B 0.00
Korro Bio (KRRO) United States $0.190B 0.00
China SXT Pharmaceuticals (SXTC) China $0.186B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.167B 25.75
Journey Medical (DERM) United States $0.162B 0.00
MEI Pharma (MEIP) United States $0.158B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Avita Medical (RCEL) United States $0.150B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.130B 0.00
Profound Medical (PROF) Canada $0.128B 0.00
Avalo Therapeutics (AVTX) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.110B 0.00
Liminatus Pharma (LIMN) United States $0.104B 0.00
Dominari Holdings (DOMH) United States $0.098B 0.00
Surrozen (SRZN) United States $0.095B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.38
BioNxt Solutions (BNXTF) Canada $0.086B 0.00
VAXART, INC (VXRT) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Context Therapeutics (CNTX) United States $0.071B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Inotiv (NOTV) United States $0.065B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
DURECT (DRRX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Karyopharm Therapeutics (KPTI) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Wellgistics Health (WGRX) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 28.45
Tempest Therapeutics (TPST) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Enlivex Therapeutics (ENLV) Israel $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Klotho Neurosciences (KLTO) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
FibroGen (FGEN) United States $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Mural Oncology (MURA) Ireland $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.029B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.020B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.02
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.18
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.52
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00